Hepatitis A vaccine
Hepatitis A vaccine is a biological therapy with 28 clinical trials. Currently 5 active trials ongoing. Historical success rate of 88.9%.
Success Metrics
Based on 16 completed trials
Phase Distribution
Phase Distribution
2
Early Stage
7
Mid Stage
16
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
88.9%
16 of 18 finished
11.1%
2 ended early
5
trials recruiting
28
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
The COVID-19 VaccinE Response and Co-Administration in Rheumatology Patients (COVER-CoAd)
Study of a Quadrivalent Meningococcal Conjugate Vaccine (MenACYW Conjugate Vaccine) Given With Routine Pediatric Vaccines in Healthy Infants and Toddlers in India and the Republic of South Africa
A Study on the Immune Response and Safety of an Investigational Chickenpox Vaccine and a Marketed Measles, Mumps and Rubella Vaccine When Administered as Intramuscular Injection to Healthy Children 12 to 15 Months of Age
A Study on the Immune Response and Safety of the Second Dose of an Investigational Chickenpox Vaccine When Given to Healthy Children 3 Months After a First Dose at 12 to 15 Months of Age
Transmission Reduction and Prevention With HPV Vaccination (TRAP-HPV) Study
Clinical Trials (28)
The COVID-19 VaccinE Response and Co-Administration in Rheumatology Patients (COVER-CoAd)
Study of a Quadrivalent Meningococcal Conjugate Vaccine (MenACYW Conjugate Vaccine) Given With Routine Pediatric Vaccines in Healthy Infants and Toddlers in India and the Republic of South Africa
A Study on the Immune Response and Safety of an Investigational Chickenpox Vaccine and a Marketed Measles, Mumps and Rubella Vaccine When Administered as Intramuscular Injection to Healthy Children 12 to 15 Months of Age
A Study on the Immune Response and Safety of the Second Dose of an Investigational Chickenpox Vaccine When Given to Healthy Children 3 Months After a First Dose at 12 to 15 Months of Age
Transmission Reduction and Prevention With HPV Vaccination (TRAP-HPV) Study
A Study on the Immune Response and Safety of an Investigational Chickenpox Vaccine When Given to Healthy Children 12 to 15 Months of Age
A Study on the Immune Response and Safety of Various Potencies of an Investigational Chickenpox Vaccine Compared With a Marketed Chickenpox Vaccine, Given to Healthy Children 12 to 15 Months of Age
A Study on the Safety of an Investigational Chickenpox Vaccine, When Given to Healthy Children, 12 to 15 Months of Age
PCV13 + Hepatitis a Vaccine for Adults
Immunogenicity and Safety of a Quadrivalent Meningococcal Conjugate Vaccine When Administered Concomitantly With Routine Pediatric Vaccines in Healthy Infants and Toddlers in the US
Immunogenicity Study of an Inactivated Hepatitis A Vaccine in Infants and Young Children
Persistence of Hepatitis A Antibody in Healthy Adults ~32 Years Post Vaccination.
A Dose-Confirmation Study to Evaluate the Safety, Reactogenicity and Immunogenicity of Vaccine CVnCoV in Healthy Adults for COVID-19
Phase 1 Study of MGD010 in Healthy Subjects
A Study to Compare the Efficacy of Hepatitis A Vaccine and Immune Globulin When Given After Exposure to Hepatitis A
Qualitative, Qualitative, and Functional Studies Over the First Year in Measuring Immune System Response During the First Year of Therapy in Patients With Brain Tumors
Safety and Immunogenicity of Norovirus GI.1/GII.4 Bivalent VLP Vaccine
Comparative Immunogenicity Study of Two Hepatitis A Vaccines
A Controlled Study to Evaluate the Safety and Immunogenicity of StreptAnova™ in Healthy Adults
Improving the Immune System With Human IL-7 Vaccine in Older Subjects Who Have Had Chemotherapy
Drug Details
- Intervention Type
- BIOLOGICAL
- Total Trials
- 28